2,290
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Pyoderma gangrenosum with pulmonary involvement: a pulmonary special report and literature review

, , , , , & ORCID Icon show all
Pages 149-159 | Received 30 Jan 2021, Accepted 07 Jan 2022, Published online: 24 Jan 2022

References

  • Prat L, Bouaziz JD, Wallach D, et al. Neutrophilic dermatoses as systemic diseases. Clin Dermatol. 2014 May-Jun;32(3):376–388. •• This paper provides a review of neutrophilic dermatoses together with different extrareview of neutrophilic dermatoses together with different extracutaneous manifestations of the disease
  • Borda LJ, Wong LL, Marzano AV, et al. Extracutaneous involvement of pyoderma gangrenosum. Arch Dermatol Res. 2019 Aug;311(6):425–434.
  • Monari P, Moro R, Motolese A, et al. Epidemiology of pyoderma gangrenosum: results from an Italian prospective multicentre study. Int Wound J. 2018 Dec;15(6):875–879.
  • Alavi A, French LE, Davis MD, et al. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2017 Jun;18(3):355–372.
  • Annese V. A review of extraintestinal manifestations and complications of inflammatory bowel disease. Saudi J Med Med Sci. 2019 May-Aug;7(2):66–73.
  • Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000 Jan;79(1):37–46.
  • Wang JY, French LE, Shear NH, et al. Drug-induced pyoderma gangrenosum: a review. Am J Clin Dermatol. 2018 Feb;19(1):67–77.
  • Akanay-Diesel S, Hoff NP, Kürle S, et al. Sunitinib induced pyoderma gangrenosum-like ulcerations. Eur J Med Res. 2011 Nov 10;16(11):491–494.
  • Callen JP. Pyoderma gangrenosum. Lancet. 1998 Feb 21;351(9102):581–585.
  • Jockenhöfer F, Wollina U, Salva KA, et al. The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum. Br J Dermatol. 2019 Mar;180(3):615–620.
  • Gupta AS, Greiling TM, Ortega-Loayza AG. A systematic review of pyoderma gangrenosum with pulmonary involvement: clinical presentation, diagnosis and management. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e295–e297.
  • Xu P, Cai Y, Ying X, et al. A case of persistent fever, cutaneous manifestations and pulmonary and splenic nodules: clinical experience and a literature review. Intern Med J. 2019 Feb;49(2):247–251.
  • Li X, Chandra S. A case of ulcerative colitis presenting as pyoderma gangrenosum and lung nodule. J Community Hosp Intern Med Perspect. 2014 Feb 17;4(1). doi:https://doi.org/10.3402/jchimp.v4.23402.
  • Marchiori E, Hochhegger B, Guimarães MD, et al. A cutaneous ulceration with pulmonary mass. Neth J Med. 2014 Apr;72(3):152–156.
  • Brown TS, Marshall GS, Callen JP. Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol. 2000 Jul;43(1 Pt 1):108–112.
  • Sartini A, Bianchini M, Schepis F, et al. Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection. Clin Case Rep. 2016 Jan 2;4(2):195–202.
  • Bostan E, Günaydın SD, Karaduman A, et al. Excellent response to bortezomib in a patient with widespread ulcerative pyoderma gangrenosum accompanied by pulmonary involvement and IgA monoclonal gammopathy. Int Wound J. 2019 Aug;16(4):1052–1054. • This paper describes the use of Bortezomib in management of pyoderma gangrenosum
  • Mercer JM, Kuzel P, Mahmood MN, et al. Fatal case of vulvar pyoderma gangrenosum with pulmonary involvement: case presentation and literature review. J Cutan Med Surg. 2014 Nov;18(6):424–429.
  • Bittencourt Mde J, Soares LF, Lobato LS, et al. Multiple cavitary pulmonary nodules in association with pyoderma gangrenosum: case report. An Bras Dermatol. 2012 Mar-Apr;87(2):301–304.
  • Be M, Cha HJ, Park C, et al. Multiple pulmonary cavitary nodules with pyoderma gangrenosum in patient with rheumatoid arthritis. Ann Transl Med. 2016 Jan;4(2):39.
  • Kasuga I, Yanagisawa N, Takeo C, et al. Multiple pulmonary nodules in association with pyoderma gangrenosum. Respir Med. 1997 Sep;91(8):493–495.
  • Krüger S, Piroth W, Amo Takyi B, et al. Multiple aseptic pulmonary nodules with central necrosis in association with pyoderma gangrenosum. Chest. 2001 Mar;119(3):977–978.
  • Allen CP, Hull J, Wilkison N, et al. Pediatric pyoderma gangrenosum with splenic and pulmonary involvement. Pediatr Dermatol. 2013 Jul-Aug;30(4):497–499.
  • Kitagawa KH, Grassi M. Primary pyoderma gangrenosum of the lungs. J Am Acad Dermatol. 2008 Nov;59(5 Suppl):S114–6.
  • Gade M, Studstrup F, Andersen AK, et al. Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature. Respir Med. 2015 Apr;109(4):443–450.
  • Chahine B, Chenivesse C, Tillie-Leblond I, et al. Pulmonary manifestations of pyoderma gangrenosum. Presse Med. 2007 Oct;36(10 Pt 1):1395–1398.
  • Contreras-Verduzco FA, Espinosa-Padilla SE, Orozco-Covarrubias L, et al. Pulmonary nodules and nodular scleritis in a teenager with superficial granulomatous pyoderma gangrenosum. Pediatr Dermatol. 2018 Jan;35(1):e35–e38.
  • Sakata KK, Penupolu S, Colby TV, et al. Pulmonary pyoderma gangrenosum without cutaneous manifestations. Clin Respir J. 2016 Jul;10(4):508–511.
  • Matsumura Y, Nishiwaki F, Morita N, et al. Pyoderma gangrenosum in a patient with myelodysplastic syndrome followed by possible extracutaneous manifestations in the gallbladder, liver, bone and lung. J Dermatol. 2011 Nov;38(11):1102–1105.
  • Scherlinger M, Guillet S, Doutre MS, et al. Pyoderma gangrenosum with extensive pulmonary involvement. J Eur Acad Dermatol Venereol. 2017 Apr;31(4):e214–e216.
  • Wang JL, Wang JB, Zhu YJ. Pyoderma gangrenosum with lung injury. Thorax. 1999 Oct;54(10):953–955.
  • Vignon-Pennamen MD, Zelinsky-Gurung A, Janssen F, et al. Pyoderma gangrenosum with pulmonary involvement. Arch Dermatol. 1989 Sep;125(9):1239–1242.
  • Fukuhara K, Urano Y, Kimura S, et al. Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone. Br J Dermatol. 1998 Sep;139(3):556–558.
  • Maritsi DN, Tavernaraki K, Vartzelis G. Pyoderma gangrenosum with systemic and pulmonary involvement in a toddler. Pediatr Int. 2015 Jun;57(3):505–506.
  • Kanoh S, Kobayashi H, Sato K, et al. Tracheobronchial pulmonary disease associated with pyoderma gangrenosum. Mayo Clin Proc. 2009 Jun;84(6):555–557.
  • Lebbé C, Moulonguet-Michau I, Perrin P, et al. Steroid-responsive pyoderma gangrenosum with vulvar and pulmonary involvement. J Am Acad Dermatol. 1992 Oct;27(4):623–625.
  • Mlika RB, Riahi I, Fenniche S, et al. Pyoderma gangrenosum: a report of 21 cases. Int J Dermatol. 2002 Feb;41(2):65–68.
  • Batalla A, Pérez-Pedrosa A, García-Doval I, et al. Pioderma gangrenoso con afectación pulmonar: caso clínico y revisión de la literatura [Lung involvement in pyoderma gangrenosum: a case report and review of the literature]. Actas Dermosifiliogr. 2011 Jun; 102(5): 373–377. Spanish
  • Bhat M, Dawson D. Wheezes, blisters, bumps and runs: multisystem manifestations of a Crohn’s disease flare-up. Cmaj. 2007 Sep 25;177(7):715–718.
  • Merke DP, Honig PJ, Potsic WP. Pyoderma gangrenosum of the skin and trachea in a 9-month-old boy. J Am Acad Dermatol. 1996 Apr;34(4):681–682.
  • Deregnaucourt D, Buche S, Coopman S, et al. Pyoderma gangrenosum avec localisations pulmonaires traité par infliximab [Pyoderma gangrenosum with lung involvement treated with infliximab]. Ann Dermatol Venereol. 2013 May; 140(5): 363–366. French
  • Field S, Powell FC, Young V, et al. Pyoderma gangrenosum manifesting as a cavitating lung lesion. Clin Exp Dermatol. 2008 Jul;33(4):418–421.
  • Rajan N, Das S, Taylor A, et al. Idiopathic infantile pyoderma gangrenosum with stridor responsive to infliximab. Pediatr Dermatol. 2009 Jan-Feb;26(1):65–69.
  • Watanabe M, Natsuga K, Ota M, et al. Pyoderma gangrenosum associated with acute respiratory distress syndrome. Am J Med. 2016 Feb;129(2):e17–8.
  • Poiraud C, Gagey-Caron V, Barbarot S, et al. Pyoderma gangrenosum cutanéomuqueux et systémique [cutaneous, mucosal and systemic pyoderma gangrenosum]. Ann Dermatol Venereol. 2010 Mar; 137(3): 212–215. French
  • Mirkamali A, Martha B, Dutronc Y, et al. Abcès pulmonaire et pyoderma gangrenosum [pulmonary abscess and pyoderma gangrenosum]. Med Mal Infect. 2007 Dec; 37(12): 835–839. French
  • Takeuchi K, Kyoko H, Hachiya M, et al. Pyoderma gangrenosum of the skin and respiratory tract in a 5-year-old girl. Eur J Pediatr. 2003 May;162(5):344–345.
  • Sasaki T, Miura K, Kurokawa H, et al. [Interstitial pneumonia associated with pyoderma gangrenosum successfully treated with cyclosporine A]. Nihon Naika Gakkai Zasshi. 2003 Jan 10;92(1):146–148. Japanese
  • Grattan CE, McCann BG, Lockwood CM. Pyoderma gangrenosum, polyarthritis and lung cysts with novel antineutrophil cytoplasmic antibodies to azurocidin. Br J Dermatol. 1998 Aug;139(2):352–353.
  • Liu ZH, Lu XL, Fu MH, et al. Pyoderma gangrenosum with pulmonary involvement? Eur J Dermatol. 2008 Sep-Oct;18(5):583–585.
  • Vignon-Pennamen MD, Wallach D. Cutaneous manifestations of neutrophilic disease. A study of seven cases. Dermatologica. 1991;183(4):255–264.
  • Peters FP, Drent M, Verhaegh M, et al. Myelodysplasia presenting with pulmonary manifestations associated with neutrophilic dermatosis. Ann Hematol. 1998 Sep;77(3):135–138.
  • Shands JW Jr, Flowers FP, Hill HM, et al. Pyoderma gangrenosum in a kindred. Precipitation by surgery or mild physical trauma. J Am Acad Dermatol. 1987;16(5 Pt 1):931–934.
  • Urano S, Kodama H, Kato K, et al. Pyoderma gangrenosum with systemic involvement. J Dermatol. 1995 Jul;22(7):515–519.
  • Kędzierska MA, Szmurło A, Szymańska E, et al. Pyoderma gangrenosum with visceral involvement: a severe, recurrent disease affecting pulmonary, splenic, mesorectal, and subcutaneous tissues. Pol Arch Intern Med. 2020;130(7–8):688–690.
  • Gallou S, Madelaine J, Planchard G, et al. Atteinte pulmonaire de pyoderma gangrenosum: discussion diagnostique et thérapeutique à partir d’un cas et d’une revue ciblée de la littérature [lung involvement of pyoderma gangrenosum: diagnostic and therapeutic discussion based on a case report and a targeted literature review]. Rev Med Interne. 2021;42(10):734–739. • This paper describes the use of Tofactinib in management of pyoderma gangrenosum
  • Hooton TA, Hanson JF, Olerud JE. Recalcitrant cutaneous pyoderma gangrenosum with pulmonary involvement resolved with treatment of underlying plasma cell dyscrasia. JAAD Case Rep. 2021;9:28–30.
  • Arai S, Furukawa N, Takahama M, et al. Extracutaneous neutrophilic infiltration of the spleen and lung associated with pyoderma gangrenosum of the skin [published online ahead of print, 2021 Dec 14]. Clin Exp Dermatol. 2021. DOI:https://doi.org/10.1111/ced.15065.
  • Wallach D, Vignon-Pennamen MD. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol. 2006 Dec;55(6):1066–1071.
  • Basnyat B, Caws M, Udwadia Z. Tuberculosis in South Asia: a tide in the affairs of men. Multidiscip Respir Med. 2018 Mar 22;13:10.
  • Solovic I, Sester M, Gomez-Reino JJ, et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J. 2010 Nov;36(5):1185–1206.
  • Strong MS. Cough, dyspnea and stridor. Med Clin North Am. 1957 Sep;41(5):1255–1266.